Welcome to paragraphfour.com and The Paragraph Four Report. I hope you find it interesting and informative. As generic companies file more and more ANDAs with Paragraph IV certifications and challenge patents of marketed pharmaceutical products, The Paragraph Four Report offers a convenient location for information surrounding this activity.

The real heart of The Paragraph Four Report is found in the Paragraph IV Activity section. There, you will find powerful, searchable databases regarding products under Paragraph IV challenge as well as General Reports which provide data on the big picture of Paragraph IV activity. These sections are available to subscribers only. We have also added sections for investors and on pending legislation. For more information about subscribing, please contact us at info@paragraphfour.com .

The site also contains a great deal of background information regarding the generic approval process and its incumbent reliance on Paragraph IV certifications. This information is also available to subscribers and non-subscribers.

The Paragraph Four Report is an electronic publication of Parry Ashford Inc. and is dedicated to mining, tracking, and analyzing Paragraph Four activity as it affects pharmaceutical products, generic and branded companies, and the pharmaceutical industry.

The Paragraph Four Report includes information regarding which companies are filing ANDA applications with Paragraph IV certifications, which products are being challenged, and the status of pending court cases. It also includes information regarding recently passed or pending legislation.

Parry Ashford is a research and publishing firm located in Exton, PA. In creating the Paragraph Four Report, Parry Ashford obtains its information from public sources and attempts to present the information in an unbiased, factual, and balanced manner. It does not speculate on outcomes of Paragraph IV challenges and court cases and does not accept advertising nor endorses any company or service provider.

In providing the Paragraph Four Report, Parry Ashford provides data for information purposes only.   It does not independently verify facts as provided by public sources nor attempts to provide legal or investing advice. Any reliance on data provided by the Paragraph Four Report is done solely at the discretion of the user.

Thank you for your interest. As The Paragraph Four Report evolves along with the market, we always welcome your thoughts, comments, and feedback. Please feel free to contact me at editor@paragraphfour.com .

Gregory Glass JD, MBA
 

Gregory Glass is the Editor of The Paragraph Four Report. He holds a JD from Vanderbilt University and an MBA from Duke University. While a practicing attorney, he litigated many cases in state and federal courts. His most memorable case was presenting the winning argument in a $15M case involving a question of constitutional law. He has worked in the pharmaceutical industry since 1995 in a variety of business and legal capacities, including market research and product strategy.

The Paragraph Four Report, ParagraphFour.com, and the PFOUR logo are registered trademarks of Parry Ashford Inc. • © Parry Ashford Inc. 2017